vimarsana.com
Home
Live Updates
Keeping Track of Your Data — What You Need to Know about FDAs Draft Guidance on Data Integrity for In Vivo Bioavailability and Bioequivalence Studies | Foley & Lardner LLP : vimarsana.com
Keeping Track of Your Data — What You Need to Know about FDA's Draft Guidance on Data Integrity for In Vivo Bioavailability and Bioequivalence Studies | Foley & Lardner LLP
Given data integrity issues that have been uncovered in the past, in April 2024, the U.S. Food and Drug Administration (FDA) published a draft guidance to applicants and testing site...
Related Keywords
,
Drug Administration
,
Foley Lardner
,
Alcoa
,
Drug Evaluation
,
Study Sponsors Can Take
,
Ensure Data
,
Testing Sites Can Take
,
vimarsana.com © 2020. All Rights Reserved.